ANG Lifesciences India Limited (BOM:540694)
India · Delayed Price · Currency is INR 34.09
+0.66 (1.97%)
At close: Sep 4, 2026
ANG Lifesciences India Market Cap
ANG Lifesciences India has a market cap or net worth of 445.16 million as of September 4, 2026. Its market cap has increased by 34.96% in one year.
Market Cap
445.16M
Enterprise Value
1.20B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
34.09
ChartMarket Cap Chart
Since September 8, 2017, ANG Lifesciences India's market cap has decreased from 497.60M to 445.16M, a decrease of -10.54%. That is a compound annual growth rate of -1.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 445.16M | 15.36% |
| Dec 31, 2025 | 385.87M | -33.77% |
| Dec 31, 2024 | 582.66M | -35.72% |
| Dec 29, 2023 | 906.38M | -42.23% |
| Dec 30, 2022 | 1.57B | -67.78% |
| Dec 31, 2021 | 4.87B | 1,136.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phaarmasia | 563.91M |
| Shelter Pharma | 532.04M |
| Biofil Chemicals and Pharmaceuticals | 515.88M |
| Parmax Pharma | 495.54M |
| Mangalam Drugs & Organics | 480.39M |
| Rajnish Wellness | 406.14M |
| Vista Pharmaceuticals | 386.55M |
| Panjon | 384.49M |